These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18511249)

  • 1. 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.
    Elangbam CS; Job LE; Zadrozny LM; Barton JC; Yoon LW; Gates LD; Slocum N
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):253-62. PubMed ID: 18511249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of glycosaminoglycans content and 5-hydroxytryptamine 2B receptor in the heart valves of Sprague-Dawley rats with spontaneous mitral valvulopathy--a possible exacerbation by dl-amphetamine sulfate in Fischer 344 rats?
    Elangbam CS; Wehe JG; Barton JC; Krull DL; Nyska A; Crabbs T; Kissling GE
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):89-99. PubMed ID: 16996724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxytryptamine (5HT) receptors in the heart valves of cynomolgus monkeys and Sprague-Dawley rats.
    Elangbam CS; Lightfoot RM; Yoon LW; Creech DR; Geske RS; Crumbley CW; Gates LD; Wall HG
    J Histochem Cytochem; 2005 May; 53(5):671-7. PubMed ID: 15872060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose dependency and reversibility of serotonin-induced valvular heart disease in rats.
    Droogmans S; Roosens B; Cosyns B; Degaillier C; Hernot S; Weytjens C; Garbar C; Caveliers V; Pipeleers-Marichal M; Franken PR; Bossuyt A; Schoors D; Lahoutte T; Van Camp G
    Cardiovasc Toxicol; 2009 Sep; 9(3):134-41. PubMed ID: 19609730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of subendocardial cell proliferation in the rat and relevance for understanding drug-induced valvular heart disease in humans.
    Fielden MR; Hassani M; Uppal H; Day-Lollini P; Button D; Martin RS; Garrido R; Liu X; Kolaja KL
    Exp Toxicol Pathol; 2010 Nov; 62(6):607-13. PubMed ID: 19781924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term serotonin administration induces heart valve disease in rats.
    Gustafsson BI; Tømmerås K; Nordrum I; Loennechen JP; Brunsvik A; Solligård E; Fossmark R; Bakke I; Syversen U; Waldum H
    Circulation; 2005 Mar; 111(12):1517-22. PubMed ID: 15781732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Serotonin Interacts with Angiotensin-II to Result in Altered Valve Interstitial Cell Contractility and Remodeling.
    Perez J; Diaz N; Tandon I; Plate R; Martindale C; Balachandran K
    Cardiovasc Eng Technol; 2018 Jun; 9(2):168-180. PubMed ID: 28247311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term serotonin effects in the rat are prevented by terguride.
    Hauso Ø; Gustafsson BI; Loennechen JP; Stunes AK; Nordrum I; Waldum HL
    Regul Pept; 2007 Oct; 143(1-3):39-46. PubMed ID: 17391782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of 5HT-1A and 5HT-1B receptor genes in brains of Wistar-Zagreb 5HT rats.
    Bordukalo-Niksić T; Mokrović G; Jernej B; Cicin-Sain L
    Coll Antropol; 2008 Jan; 32 Suppl 1():37-41. PubMed ID: 18405056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced valvulopathy: an update.
    Elangbam CS
    Toxicol Pathol; 2010 Oct; 38(6):837-48. PubMed ID: 20716786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of brain and platelet serotonin transporters in sublines of rats with constitutionally altered serotonin homeostasis.
    Bordukalo-Niksic T; Cicin-Sain L; Jernej B
    Neurosci Lett; 2004 Oct; 369(1):44-9. PubMed ID: 15380305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental exposure to terbutaline and chlorpyrifos: pharmacotherapy of preterm labor and an environmental neurotoxicant converge on serotonergic systems in neonatal rat brain regions.
    Aldridge JE; Meyer A; Seidler FJ; Slotkin TA
    Toxicol Appl Pharmacol; 2005 Mar; 203(2):132-44. PubMed ID: 15710174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
    Hendrikx M; Van Dorpe J; Flameng W; Daenen W
    J Heart Valve Dis; 1996 Mar; 5(2):235-7. PubMed ID: 8665020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rats with constitutionally upregulated/downregulated platelet 5HT transporter: differences in anxiety-related behavior.
    Hranilovic D; Cicin-Sain L; Bordukalo-Niksic T; Jernej B
    Behav Brain Res; 2005 Dec; 165(2):271-7. PubMed ID: 16139900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness.
    Balachandran K; Bakay MA; Connolly JM; Zhang X; Yoganathan AP; Levy RJ
    Ann Thorac Surg; 2011 Jul; 92(1):147-53. PubMed ID: 21718840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of serotonin synaptic proteins in brain regions of neonatal Rhesus monkeys exposed to perinatal environmental tobacco smoke.
    Slotkin TA; Pinkerton KE; Tate CA; Seidler FJ
    Brain Res; 2006 Sep; 1111(1):30-5. PubMed ID: 16876770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transmembrane transporter is down-regulated in late-stage canine degenerative mitral valve disease.
    Scruggs SM; Disatian S; Orton EC
    J Vet Cardiol; 2010 Dec; 12(3):163-9. PubMed ID: 21036114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alterations in CNS serotonergic mechanisms caused by neonatal chlorpyrifos exposure are permanent.
    Slotkin TA; Seidler FJ
    Brain Res Dev Brain Res; 2005 Aug; 158(1-2):115-9. PubMed ID: 16024092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy.
    Cavero I; Guillon JM
    J Pharmacol Toxicol Methods; 2014; 69(2):150-61. PubMed ID: 24361689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.